Legal & General Group
VTVT icon

Legal & General Group’s vTv Therapeutics VTVT Stock Holding History

Legal & General Group’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-48
Closed -$5K – 3655
2021
Q1 		$5K Hold
48
– – ﹤0.01% 3481
2020
Q4 		$4K Hold
48
– – ﹤0.01% 3450
2020
Q3 		$3K Hold
48
– – ﹤0.01% 3419
2020
Q2 		$4K Buy
+48
New +$4.74K ﹤0.01% 3395
2018
Q2 		– Sell
-22
Closed -$4K – 3388
2018
Q1 		$4K Hold
22
– – ﹤0.01% 3262
2017
Q4 		$5K Hold
22
– – ﹤0.01% 3263
2017
Q3 		$5K Hold
22
– – ﹤0.01% 3295
2017
Q2 		$4K Hold
22
– – ﹤0.01% 3346
2017
Q1 		$6K Sell
22
-31
-58% -$7.07K ﹤0.01% 3234
2016
Q4 		$10K Buy
+53
New +$12.2K ﹤0.01% 3213

Other funds holding VTVT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WAG
Winthrop Advisory Group Boston, Massachusetts $1.48B AUM 22.62% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Legal & General Group's VTVT Position: Q2 2021 in Review

Legal & General Group sold out of vTv Therapeutics (VTVT) in Q2 2021, closing a stake of 48 shares — an estimated $5K sold.

Legal & General Group first reported a position in VTVT in Q4 2016 and held it in 10 quarters. The position peaked at $10K in Q4 2016. 42 funds tracked by Wall St. Rank hold VTVT as of Q2 2021.

  • Legal & General Group reported no remaining vTv Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Legal & General Group sold 48 vTv Therapeutics shares in Q2 2021, an estimated $5K.
  • Legal & General Group first reported a position in vTv Therapeutics in Q4 2016 and held it in 10 quarters.
  • Legal & General Group's vTv Therapeutics position peaked at $10K in Q4 2016.
  • 42 funds tracked by Wall St. Rank held vTv Therapeutics as of Q2 2021.

Based on Legal & General Group's 13F filing for Q2 2021, filed 12 Aug 2021.